Premium
How much imatinib is enough?
Author(s) -
Ross David M.
Publication year - 2021
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.17444
Subject(s) - imatinib , discontinuation , dasatinib , medicine , tyrosine kinase , hematology , tyrosine kinase inhibitor , oncology , imatinib mesylate , myeloid leukemia , cancer , receptor